Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors
Moritz Schütte(Alacris (Germany)), Marie‐Laure Yaspo(Max Planck Institute for Molecular Genetics), Pilar Garin‐Chesa(Medical University of Vienna), Reinhold Schäfer(Charité - Universitätsmedizin Berlin), Dirk Wienke(Merck KGaA, Darmstadt (Germany)), Stephan Beck(Wellcome Sanger Institute), Dirk Schumacher(German Cancer Research Center), Sandra Liebs(Charité - Universitätsmedizin Berlin), Hans Lehrach(Max Planck Institute for Molecular Genetics), James E. Barrett(Universität Innsbruck), Joseph L. Regan(Bayer (Germany)), Reha Yildiriman(Alacris (Germany)), Karsten Boehnke(Eli Lilly (Spain)), Christoph Wierling(Alacris (Germany)), Lee M Butcher(University College London), Inge Kehler(Charité - Universitätsmedizin Berlin), Christian Regenbrecht(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Stefan Uranitsch(Graz University Hospital), Nilofar Abdavi-Azar(Max Planck Institute for Molecular Genetics), Maxine Silvestrov(Helios Hospital Berlin-Buch), Yvonne Welte(Helios Hospital Berlin-Buch), Vyacheslav Amstislavskiy(Max Planck Institute for Molecular Genetics), Catherine L. Worth(Max Planck Institute for Molecular Genetics), Ralf Herwig(Max Planck Institute for Molecular Genetics), Nicole Golob‐Schwarzl(Medical University of Graz), Sigurd Lax(Graz University Hospital), Christine Jandrasits(Max Planck Institute for Molecular Genetics), Hans-Jörg Warnatz(Max Planck Institute for Molecular Genetics), Alberto Fusi(Charité - Universitätsmedizin Berlin), Martin Lange(Bayer (Germany)), Bodo Lange(Alacris (Germany)), Ulrich Keilholz(Berliner Hochschule für Technik), Ulf Landegren(Uppsala University), Caroline Schweiger(Medical University of Graz), Christoph Reinhard(Eli Lilly (United States)), Tatiana Borodina(Alacris (Germany)), Juan A. Velasco(Eli Lilly (Spain)), T. Keßler(Alacris (Germany)), David Henderson(Bayer (Germany)), Johannes Haybaeck(Medical University of Graz), Marlen Keil(Helios Hospital Berlin-Buch), Michael W. Becker(Helios Hospital Berlin-Buch), Marc Sultan(Max Planck Institute for Molecular Genetics), Mats Nilsson(Stockholm University), Thomas S. Risch(Max Planck Institute for Molecular Genetics), Jens Hoffmann(Helios Hospital Berlin-Buch)
Cited by 348
Related Papers
A global reference for human genetic variation
|Nature|2015|19.9k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene Promoters
|Cell|2016|1.2k